Inventor
STEVEN MISCHKE
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
12,378,242Inhibiting CREB binding protein (CBP)202512,351,577Inhibiting cyclic AMP-responsive element-binding protein (CREB)202512,252,490Inhibiting deubiquitinase USP25 and USP28202511,814,386Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors202311,787,803Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors202311,535,618Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors202211,325,917Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors202211,292,791Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors202211,254,674Inhibiting CREB binding protein (CBP)202211,247,987Inhibiting ubiquitin specific peptidase 302022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to FORMA THERAPEUTICS INC (8)· patent assignee history
2022–2025Patents assigned to VALO HEALTH INC (2)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FORMA THERAPEUTICS INC | 8 | 2022–2025 |
| VALO HEALTH INC | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2025 |